Shlomo Pilo - Dec 5, 2022 Form 4 Insider Report for Raphael Pharmaceutical Inc. (RAPH)

Role
Chief Executive Officer, Director, 10%+ Owner
Signature
/s/ Shlomo Pilo
Stock symbol
RAPH
Transactions as of
Dec 5, 2022
Transactions value $
$0
Form type
4
Date filed
3/13/2023, 04:03 PM
Previous filing
Jan 19, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RAPH Warrants to Purchase Common Stock Award $0 +1M $0.00 1M Dec 5, 2022 Common Stock 1M $1.12 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The warrants are exercisable immediately.